Navigation Links
Iodex goes to SmithKline Beecham consumer Healthcare

Iodex is the market leader in the pain-balm segment, with a market share of 70 per cent-plus. Iodex faces challenges from local brands like Amrutanjan, Tiger Balm (locally manufactured by Elder Pharma), Zandu Balm and Sensur of Glenmark. //

Glaxo SmithKline India (GSK) has decided to transfer its Iodex range of products to SmithKline Beecham Consumer Healthcare (SKBCH), a GSK subsidiary. SKBCH has a strong marketing and distribution network in India, comprising over 1,600 wholesalers and direct coverage of over 4,00,000 retail outlets.

Last year, Glaxo India and SmithKline Beecham Pharmaceutical India had merged and it was announced that the focus of the merged entity, GSK, would give more focus on prescription drugs and vaccines rather than over-the-counter (OTC) products. The officials said with this transfer of the Iodex brand, the entire promotion, marketing and distribution will be carried out by SKBCH, a leading player in the OTC segment.

The Iodex brand was owned by SmithKline Beecham Plc, the British parent, and had been licensed to SmithKline Beecham Pharmaceuticals India. Iodex has a turnover of around Rs 100 crore, and analysts say it could be valued at Rs 300 crore. The pain-and-rub market in India is currently valued in the Rs 350-400 crore range.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Generic Products Compete With GlaxoSmithKline
8. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
9. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
10. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
11. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... , ... March 01, 2017 , ... ... healing grace in the lives of those who hear His voice. “Cleansing Thoughts; ... a retired Christian bookstore proprietor who enjoys boating, gardening and crocheting baby items ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a tale of young love ... survivor of the Civil War in El Salvador, wife, mother, and co-founder of a ... I dedicated myself to serve in very poor communities, and I study psychology. I ...
(Date:3/1/2017)... DENVER, Colo. (PRWEB) , ... March 01, 2017 ... ... solutions to the marijuana industry, today unveiled its Cannabis Compliance Program for Regulatory ... legal medical marijuana industry to provide regulators with internal or outsourced compliance program ...
(Date:2/28/2017)... ... March 01, 2017 , ... ... of SmarterMe, a personal assistant for sales powered by an intelligent mobile platform ... work smarter. , SmarterMe is built grounds up keeping individual users in mind ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... Answering ... Area, Orthogonal LLC will open a branch office in the Soma neighborhood ... growing Bay Area staff human factors, FDA regulatory and software systems architecture subject matter ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Calif. , March 1, 2017   Sun Chlorella ... about all things chlorella, is pleased to announce Non-GMO Project ... premium chlorella powder. Just in time for the ... in Anaheim, CA , Sun Chlorella Corp. ... all chlorella products, including: Sun Chlorella ...
(Date:3/1/2017)... 2017  Integrated Modular Design (IMD), a ... implementation of pre-fabricated healthcare products like bathroom ... seeks to lead the construction industry toward ... Fueled by their leading-edge pre-fabrication solutions, ... construction timelines and project risk, and increasing ...
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
Breaking Medicine Technology: